<DOC>
	<DOCNO>NCT01536314</DOCNO>
	<brief_summary>The aim study evaluate memantine administer 4 week begin 2 week surgery induces decrease painful intensity 3 month surgery , compare placebo group .</brief_summary>
	<brief_title>Prophylaxis Neuropathic Pain m√©mantine</brief_title>
	<detailed_description>The aim study evaluate memantine administer 4 week begin 2 week surgery induces decrease painful intensity 3 month surgery , compare placebo group .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>18 year old patient suffer breast cancer mastectomy/tumorectomy within clean 2 week inclusion within preemptive chemotherapy Againstindication memantine administration : hypersensitivity active substance excipients , hypertension , antecedent cerebrovascular accident , severe cardiac insufficiency Diabetic patient ( Type I II ) Patient medical surgical antecedent Patient receive treatment amantadine , ketamine , dextrometorphan , LDopa , dopaminergic , anticholinergic agonist , barbiturate , neuroleptic , IMAO , antispastic agent , dantrolen baclofen , phenitoin , cimetidine , ranitidine , procainamide , quinidine , quinine , nicotine , hydrochlorothiazide , warfarine Patient alcohol addiction Woman childbearing age use effective contraceptive method , pregnant lactate woman Patient participate another clinical trial , locate exclusion period receive benefit &gt; 4500 euro 12 month begin trial</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Pre-emptive administration</keyword>
	<keyword>Post-operative administration</keyword>
	<keyword>Prophylaxis</keyword>
	<keyword>Memantine</keyword>
	<keyword>Post-mastectomy/tumorectomy</keyword>
	<keyword>Neuropathic pain</keyword>
</DOC>